Literature DB >> 20478355

Variations of plasma leptin and adiponectin levels in autistic patients.

Patrizia Blardi1, Arianna de Lalla, Linda Ceccatelli, Guerri Vanessa, Alberto Auteri, Joseph Hayek.   

Abstract

Autism is a neurodevelopmental disorder with pathogenesis not completely understood. Although a genetic origin has been recognized, it has been hypothesized a role for environmental factors, immune dysfunctions, and alterations of neurotransmitter systems. In young autistic patients we investigated plasma leptin and adiponectin levels over a year period. Thirty-five patients, mean age at the basal time 14.1+/-5.4 years, were enrolled. Controls were 35 healthy subjects, sex and age matched. Blood samples were withdrawn in the morning at the baseline and 1 year after. In patients leptin concentrations significantly increased, while adiponectin did not significantly change. Leptin values in patients were significantly higher than those found in controls at each time; adiponectin values did not differ at each time between patients and controls. Since patients were not obese, we could hypothesize that leptin might participate to clinical manifestations other than weight balance. The role of adiponectin in autism is still debatable. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20478355     DOI: 10.1016/j.neulet.2010.05.027

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  17 in total

1.  Repositioning leptin as a therapy for Alzheimer's disease.

Authors:  Jane M Johnston; Steven J Greco; Ashkan Hamzelou; J Wesson Ashford; Nikolaos Tezapsidis
Journal:  Therapy       Date:  2011-09

Review 2.  Current perspectives on physical activity and exercise recommendations for children and adolescents with autism spectrum disorders.

Authors:  Sudha M Srinivasan; Linda S Pescatello; Anjana N Bhat
Journal:  Phys Ther       Date:  2014-02-13

Review 3.  The impact of leptin on perinatal development and psychopathology.

Authors:  Jeanette C Valleau; Elinor L Sullivan
Journal:  J Chem Neuroanat       Date:  2014-05-23       Impact factor: 3.052

4.  Evaluation of Appetite-Regulating Hormones ın Young Children with Autism Spectrum Disorder.

Authors:  Çağla Çelikkol Sadıç; Ayhan Bilgiç; İbrahim Kılınç; Mehmet Burhan Oflaz; Tamer Baysal
Journal:  J Autism Dev Disord       Date:  2021-02

5.  Serum adiponectin levels are reduced in autism spectrum disorder and association with severity of symptoms.

Authors:  Lijuan Quan; Yue Zhao; Jinping Yi; Xiao-Dong Shi; Yingjun Zhong; Lingling Liu
Journal:  Metab Brain Dis       Date:  2021-01-20       Impact factor: 3.584

6.  Association Between Gestational Weight Gain and Autism Spectrum Disorder in Offspring: A Meta-Analysis.

Authors:  Le Su; Cheng Chen; Liping Lu; Anny H Xiang; Linda Dodds; Ka He
Journal:  Obesity (Silver Spring)       Date:  2020-10-01       Impact factor: 5.002

7.  Cord and Early Childhood Plasma Adiponectin Levels and Autism Risk: A Prospective Birth Cohort Study.

Authors:  Ramkripa Raghavan; M Daniele Fallin; Xiumei Hong; Guoying Wang; Yuelong Ji; Elizabeth A Stuart; David Paige; Xiaobin Wang
Journal:  J Autism Dev Disord       Date:  2019-01

8.  Fetal and Infancy Growth Pattern, Cord and Early Childhood Plasma Leptin, and Development of Autism Spectrum Disorder in the Boston Birth Cohort.

Authors:  Ramkripa Raghavan; Barry Zuckerman; Xiumei Hong; Guoying Wang; Yuelong Ji; David Paige; Jessica DiBari; Cuilin Zhang; M Daniele Fallin; Xiaobin Wang
Journal:  Autism Res       Date:  2018-09-24       Impact factor: 5.216

9.  Altered ghrelin levels in boys with autism: a novel finding associated with hormonal dysregulation.

Authors:  Felwah S Al-Zaid; AbdelFattah A Alhader; Laila Y Al-Ayadhi
Journal:  Sci Rep       Date:  2014-09-26       Impact factor: 4.379

Review 10.  Maternal high-fat diet programming of the neuroendocrine system and behavior.

Authors:  Elinor L Sullivan; Kellie M Riper; Rachel Lockard; Jeanette C Valleau
Journal:  Horm Behav       Date:  2015-04-24       Impact factor: 3.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.